• Minerva Neurosciences Inc NERV.OQ reported a quarterly adjusted loss of 43 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.09. The lone analyst forecast for the quarter was for a loss of 90 cents per share.

• Reported revenue was zero​; analysts expected zero.

• Minerva Neurosciences Inc's reported EPS for the quarter was a loss of 43 cents​.

• Minerva Neurosciences Inc shares had risen by 4.4% this quarter and lost 19.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is "buy."

This summary was machine generated from LSEG data August 15 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)